Translational Functional Cancer Genomics
- Functional and Structural Genomics
- NCT
Prof. Dr. Hanno Glimm
Profound patient specific differences in cancer-causing aberrations as well as functional heterogeneity within individual tumors pose major challenges for the development of mechanism-based strategies in clinical cancer care.
Our Research
To understand the implications of inter- and intratumoral heterogeneity for personalized treatment approaches scientists and physicians from the Translational Functional Cancer Genomics group study the genomic and functional properties of tumor-cell subpopulations. They use their insights gained from multi-dimensional analysis of individual tumor samples and functional testing of patientderived tumor models to identify and approve novel treatment strategies.